STAGE IIB NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE IIB NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIB NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE IIB NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug before surgery shows promise against lung cancer
Disease control OngoingThis study tests whether giving the drug osimertinib before surgery can shrink tumors in people with early-stage EGFR-mutant non-small cell lung cancer. About 27 adults with stage I to IIIA disease will receive osimertinib, then have surgery. The main goal is to see how many pati…
Matched conditions: STAGE IIB NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 17, 2026 11:53 UTC
-
Precision radiation boost shows promise for tough lung cancers
Disease control OngoingThis study tested a new way of giving radiation therapy (called image-guided hypofractionated radiotherapy with a stereotactic boost) along with standard chemotherapy for people with stage II-III non-small cell lung cancer that cannot be removed by surgery. The goal was to find t…
Matched conditions: STAGE IIB NON-SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:03 UTC